A medical expert underscores the significance of infertility treatment coverage.
This expert perspective, provided by Joseph Chervenak, MD, MBA, illustrates the significant impact of infertility treatment coverage on decision-making, particularly in resource-limited populations. The focus is on the spectrum of infertility care, emphasizing alternatives to expensive treatments like IVF, such as oral medications (Clomid, letrozole) and intrauterine insemination (IUI). The influence of insurance mandates, requiring specific cycles of IUI before IVF, poses challenges for patients, affecting the success of the process, especially with aging. The introduction of frozen embryo transfer (FET) allows flexibility in timing, but insurance specifications play a role, with some requiring transfers within a specific timeframe. The evolving practice of vitrification for eggs and embryos raises questions about patient choices, including fertilization and potential options like donation or discarding. The complexity of these issues underscores the individualized nature of fertility treatments and the impact of external factors on patients' choices and outcomes.
Video synopsis is AI-generated and reviewed by Managed Health Care Executive editorial staff.
Can Lecanemab Succeed Where Aduhelm Failed?
September 28th 2022The announcement of positive phase 3 results for the investigational Alzheimer’s disease drug comes against a backdrop of Aduhelm flaming out. Both drugs are predicated on the theory that Alzheimer’s is caused by beta-amyloid deposits.
Read More